References
- Abiko M, Rodgers KE, Campeau JD et al. Alterations of angiotensin II receptor levels in sutured wounds in rat skin. J Invest Surg 1996; 9: 447–453.
- Banbury J, Siemionow M, Porvasnik S et al. Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor. Plast Reconstr Surg 2000; 106: 1541–1546.
- Bell L, Madri JA. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 1990; 137: 7–12.
- Berk BC, Vekshtein V, Gordon HM et al. Angiotensin II stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989; 13: 305–314.
- Carroll CM, Carroll SM, Schuschke DA et al. Augmen-tation of skeletal muscle flap survival using platelet derived growth factor. Plast Reconstr Surg 1998; 102: 407–415.
- Chung O, Stoll M, Unger T. Physiologic and pharma-cologic implications of ATI versus AT2 receptors. Blood Press Suppl 1996; 2: 47–52.
- Corvol P. Plouin PF. Antagonistes des recepteurs de l'angiotensine II: Indications actuelles et perspectives d'avenir. (Angiotensin II receptor blockers: current status and future prospects). Drugs 2002; 62 (suppl 1): 53–64.
- Fernandez LA, Twiclder J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 1985; 105: 141–145.
- Hickey MJ, Wilson Y, Hurley JV, Morrison WA. Mode of vascularization of control and basic fibroblast growth factor-stimulated prefabricated skin flaps. Plast Reconstr Surg 1998; 101: 1296–1306.
- Horak ER, Leek R, Klenk N et al. Angiogenesis assessed by platelet/endothelial cell adhesion molecule anti-bodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340: 1120–1124.
- Ishiguro N, Yabe Y, Shimizu T et al. Basic fibroblast growth factor has a beneficial effect on the viability of random skin flaps in rats. Ann Plast Surg 1994; 32: 356–360.
- Iwasawa M. Accelerated maturation in prefabricated flaps by transforming growth factor-beta: an experimen-tal study in the rabbit. Ann Plast Surg 1993; 31: 72–75.
- Kawahara Y, Sunako M, Tsuda T et al. Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1988; 150: 52–59.
- Kryger Z, Zhang F, Dogan T et al. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 2000; 53: 234–239.
- Le Noble FA, Hekking JW, Van Staaten HWM et al. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 1991; 195: 305–306.
- Lopez LA, Nieto CS, Garcia PB et al. Evaluation of angiogenesis in delayed skin flaps using a monoclonal antibody for the vascular endothelium. Br J Plast Surg 1995; 48: 479–486.
- Macchiarini P. Fontanini G, Hardin MJ et al. Relation of neovascularization to metastases of non-small-cell lung cancer. Lancet 1992; 340: 145–146.
- McFarlane RM, DeYoung G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg 1965; 35: 177–182.
- Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expres-sions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1419–1424.
- Nakahara K, Nishimura H, Kuroo M et al. Identification of three types of PDGF-A chain gene transcripts in rabbit vascular smooth muscle and their regulated expression during development and by angiotensin II. Biochem Biophys Res Commun 1992; 184: 811–818.
- Nall AV, Brownlee RE, Colvin CP et al. Transforming growth factor beta 1 improves wound healing and random flap survival in normal and irradiated rats. Arch Otolaryngol Head Neck Surg 1996; 122: 171–177.
- Okuyama N, Roda N, Sherman R et al. Angiotensin II improves random-flap viability in a rat model. Ann Plast Surg 1999; 42: 313–319.
- Pribaz JJ, Fine NA. Prelamination: defining the pre-fabricated flap-a case report and review. Microsurgery 1994; 15: 618–623.
- Pribaz JJ, Weiss DD, Mulliken JB et al. Prelaminated free flap reconstruction of complex central facial defects. Plast Reconstr Surg 1999; 104: 357–365.
- Rodgers KE, DeChemey AH, St Amand KM et al. Histologic alterations in dermal repair after thermal injury effects of topical angiotensin II. J Bum Care Rehabil 1997; 18: 381–388.
- Rodgers K, Xiong S, Felix J et al. Development of angiotensin (1-7) as an agent to accelerate dermal repair. Wound Repair Regen 2001; 9: 238–247.
- Stoll M, Meffert S, Stroth U et al. Growth or antigrowth: angiotensin and the endothelium. J Hypertens 1995; 13: 1529–1534.
- Stouffer GA, Owens GK. Angiotensin II induced mitogenesis of spontaneously hypertensive rat derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ Res 1992; 70: 820–828.
- Taubman MB, Berk BC, Izumo S et al. Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca+2 mobilization and protein kinase C activation. J Biol Chem 1989; 264: 526–530.
- Weidner N, Carrol PR, Flax J et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcino-ma. Am J Pathol 1993; 143: 401–409.
- Weidner N, Semple JP, Welch WR et al. Tumor angio-genesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1–8.
- Wolf G, Haberstroh U, Neilson EG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 1992; 140: 95–107.
- Zhang F, Richards L, Angel MF et al. Accelerating flap maturation by vascular endothelium growth factor in a rat tube flap model. Br J Plast Surg 2002; 55: 59–63.